Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PANX3 | Human | 1,2-dichloroethane | decreases expression | ISO | Panx3 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PANX3 mRNA | CTD | PMID:28960355 | PANX3 | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | Panx3 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of PANX3 mRNA | CTD | PMID:18648102 | PANX3 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of PANX3 gene | CTD | PMID:27153756 | PANX3 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PANX3 promoter | CTD | PMID:27901495 | PANX3 | Human | bisphenol A | increases methylation | ISO | Panx3 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of PANX3 gene | CTD | PMID:28505145 | PANX3 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PANX3 mRNA | CTD | PMID:35811015 | PANX3 | Human | N(gamma)-nitro-L-arginine methyl ester | multiple interactions | ISO | Panx3 (Mus musculus) | 6480464 | NG-Nitroarginine Methyl Ester inhibits the reaction [2-chloroethyl ethyl sulfide results in decreased expression of PANX3 mRNA] | CTD | PMID:32142722 | PANX3 | Human | oxaliplatin | increases expression | ISO | Panx3 (Rattus norvegicus) | 6480464 | oxaliplatin results in increased expression of PANX3 mRNA | CTD | PMID:25729387 | PANX3 | Human | oxaliplatin | multiple interactions | ISO | Panx3 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of PANX3 mRNA | CTD | PMID:25729387 | PANX3 | Human | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PANX3 mRNA | CTD | PMID:19710929 | PANX3 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PANX3 mRNA | CTD | PMID:35811015 | PANX3 | Human | S-(1,2-dichlorovinyl)-L-cysteine | increases expression | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in increased expression of PANX3 mRNA | CTD | PMID:35811015 | PANX3 | Human | tebuconazole | decreases expression | EXP | | 6480464 | tebuconazole results in decreased expression of PANX3 mRNA | CTD | PMID:30458266 | PANX3 | Human | topotecan | increases expression | ISO | Panx3 (Rattus norvegicus) | 6480464 | Topotecan results in increased expression of PANX3 mRNA | CTD | PMID:25729387 | PANX3 | Human | topotecan | multiple interactions | ISO | Panx3 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of PANX3 mRNA | CTD | PMID:25729387 | |